Abcam (ABCM) Dividends per Share : $0.00 (TTM As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Abcam Dividends per Share?

Abcam's dividends per share for the six months ended in Jun. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2023 was 0.00. As of today, Abcam's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Abcam was 21.90% per year. The lowest was -23.00% per year. And the median was 5.20% per year.

For more information regarding to dividend, please check our Dividend Page.

Abcam Dividends per Share Historical Data

The historical data trend for Abcam's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Dividends per Share Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Dividends per Share

Get a 7-Day Free Trial

0.12

0.15

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Abcam's Dividends per Share

For the Biotechnology subindustry, Abcam's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abcam's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abcam's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Abcam's Dividend Yield % falls into.

Abcam Dividends per Share Calculation

Dividends paid to per common share.

Abcam (NAS:ABCM) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Abcam's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0	/	0.212
	=	0.00

During the past 13 years, the highest Dividend Payout Ratio of Abcam was 0.60. The lowest was 0.26. And the median was 0.39.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Abcam was 2.17%. The lowest was 0.45%. And the median was 1.01%.

Abcam Dividends per Share Related Terms

Thank you for viewing the detailed overview of Abcam's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (ABCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (NAS:ABCM) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.